SCHEMBL8355835

SCHEMBL8355835

Cc1ccc(C2(CCN3CCOCC3)CCC2)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.45
SLC6A2 P23975 1/20 0.43
SLC6A4 P31645 1/20 0.43
SLC6A3 Q01959 1/20 0.43
OPRM1 P35372 1/20 0.41
RECQL P46063 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
TSHR P16473 1/20 0.40
TACR1 P25103 1/20 0.40
LMNA P02545 1/20 0.39
KDM4E B2RXH2 1/20 0.39
ALDH1A1 P00352 1/20 0.39
GAA P10253 1/20 0.39
HPGD P15428 1/20 0.39
CASP1 P29466 1/20 0.39
RAB9A P51151 1/20 0.39
CASP7 P55210 1/20 0.39
HSD17B10 Q99714 1/20 0.39
CACNA1H O95180 1/20 0.38
CACNA1C Q13936 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8351497 0.97 SLC6A2 (0.46) POLBSLC6A2SLC6A4SLC6A3OPRM1
SCHEMBL8352799 0.94 POLB (0.47) POLBOPRM1RECQLSMN1; SMN2TSHR
SCHEMBL8353270 0.88 HRH3 (0.50) SLC6A2SLC6A4SLC6A3SMN1; SMN2LMNA
SCHEMBL5644974 0.85 SLC6A2 (0.43) POLBSLC6A2SLC6A4SLC6A3SMN1; SMN2
SCHEMBL8353945 0.85 SLC6A2 (0.58) POLBSLC6A2SLC6A4SLC6A3SMN1; SMN2
SCHEMBL8351057 0.84 HRH3 (0.50) SLC6A2SLC6A4SLC6A3LMNA
SCHEMBL8352947 0.83 HRH3 (0.51) OPRM1SMN1; SMN2LMNA
SCHEMBL8354149 0.82 HRH3 (0.38) POLBOPRM1LMNAGAAHPGD
SCHEMBL8351474 0.82 SLC6A2 (0.62) POLBSLC6A2SLC6A4SLC6A3SMN1; SMN2
SCHEMBL8351051 0.80 KCNA3 (0.38) TACR1LMNAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7312214-B2 1, 1-disubstituted cycloalkyl derivatives as factor Xa inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 2007-12-25 US disclosed
WO-2003099276-A1 1,1-DISUBSTITUTED CYCLOALKYL DERIVATIVES AS FACTOR XA INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2003-12-04 WO disclosed